Shear-Induced Platelet Aggregation in Normal Subjects and Stroke Patients

Summary

Elevated levels of shear stress that occur in stenotic arteries may induce platelet aggregation and initiate thrombosis. Shear-induced platelet aggregation (SIPA) was studied in groups of ischemic stroke patients and normal subjects using a viscometric-flow cytometric technique. Twenty-three patients who sustained an ischemic stroke that was not of cardiac origin were included in this study, and were classified either as atherosclerotic (n = 15) or as lacunar (n = 8) stroke patients. The results show that shear stresses at the levels which occur in arteries partially occluded by atherosclerosis or vascular spasm strongly activate and aggregate platelets, and this response is much more pronounced in non-lacunar stroke patients who had documented atherosclerotic disease of their cerebral vessels. SIPA is not affected by the time of blood drawing after the onset of stroke suggesting that these platelet abnormalities are not transient but chronic. Furthermore, the extent of platelet activation detected by an anti-P-selectin monoclonal antibody and the proportion of neutrophil-platelet aggregates circulating in vivo are significantly higher in the atherosclerotic stroke patients studied at least one month after the onset of stroke. The results indicate that the enhanced platelet responses observed in atherosclerotic stroke patients are not consequences of ischemia, and therefore both platelet activation and elevated SIPA may be considered as important risk factors for stroke. The methodology developed in this work may be useful for characterization of platelet reactivity, and may contribute to our understanding of thrombotic mechanisms.

• References

• 1 Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988; 77: 1213-1220
• 2 Antiplatelet Trialists’ Collaboration. Secondary prevention of vascular events by prolonged antiplatelet therapy. BMJ 1988; 296: 320-331
• 3 Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106
• 4 Fisher M, Levine PH, Fullerton AL, Forsberg A, Duffy CP, Hoogasian JJ, Drachman DA. Marker proteins of platelet activation in patients with cerebrovascular disease. Arch Neurol 1982; 39: 692-695
• 5 Dougherty JH, Levy DE, Weksler BB. Platelet Activation in Acute Cerebral Ischemia. Serial Measurements of Platelet Function in Cerebrovascular Disease Lancet 1977; 1: 821-824
• 6 Shah AB, Beamer N, Coull BM. Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke 1985; 16: 643-647
• 7 Mulley GP, Heptinstall S, Taylor PM, Mitchell JR A. ADP-Induced Platelet Release Reaction in Acute Stroke. Thromb Haemost 1983; 50: 524-526
• 8 Uchiyama S, Takeuchi M, Osawa M, Kobayashi I, Maruyama S, Aosaki M, Hirosawa K. Platelet Function Tests in Thrombotic Cerebrovascular Disorders. Stroke 1983; 14: 511-517
• 9 Uchiyama S, Yamazaki M, Maruyama S, Handa M, Ikeda Y, Fukuyama M, Itagaki I. Shear-induced platelet aggregation in cerebral ischemia. Stroke 1994; 25: 1547-1551
• 10 Wu KK, Hoak JC. Spontaneous Platelet Aggregation in Arterial Insufficiency: Mechanisms and Implications. Thromb Haemost 1976; 35: 702-711
• 11 ten Cate JW, Vos J, Oosterhuis H, Prenger D, Jenkins CS P. Spontaneous platelet aggregation in cerebrovascular disease. Thromb Haemost 1978; 39: 223-229
• 12 Hoogendijk EM G, Jenkins CS P, van Wijk EM, Vos J, ten Cate JW. Spontaneous platelet aggregation in cerebrovascular disease II. Further characterisation of the platelet defect Thromb Haemost 1979; 41: 512-522
• 13 Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 71: 1366-1374
• 14 Peterson DM, Stathopoulos NA, Giorgio TD, Heliums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane gylcoproteins Ib and IIb-IIIa. Blood 1987; 69: 625-628
• 15 Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991; 87: 1234-1240
• 16 Adams HP, Bendixen BH, Kappelle LJ, Biller J, Liove BB, Gordon DL, Marsh III EE. And the TOAST Investigators. Classification of subtype of acute ischemic stroke Definitions for use in a multicenter clinical trial Stroke 1993; 24: 35-41
• 17 Konstantopoulos K, Wu KK, Udden MM, Bañez El, Shattil SJ, Heliums JD. Flow Cytometric Studies of Platelet Responses to Shear Stress in Whole Blood. Biorheology 1995; 32: 73-93
• 18 Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet α-granule release. Blood 1993; 82: 505-512
• 19 Coller BS, Peerschke El, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110
• 20 Goding JW. Monoclonal Antibodies: Principles and Practice. New York, NY; Academic Press Inc: 1983. pp 208-249
• 21 Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880-886
• 22 Hjemdahl P, Chronos NA F, Wilson DJ, Bouloux P, Goodall AH. Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression. Arterioscl Thromb 1994; 14: 77-84
• 23 Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987; 70: 307-315
• 24 Ault KA, Rinder HM, Mitchell JG, Rinder CS, Lambrew CT. Correlated measurement of platelet release and aggregation in whole blood. Cytometry 1989; 10: 448-455
• 25 Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991; 78: 1730-1737
• 26 Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991; 78: 1760-1769
• 27 Zar JH. Biostatistical Analysis. New Jersey; Prentice-Hall, Inc: 1984
• 28 Danta G. Second phase platelet aggregation induced by adenosine diphosphate in patients with cerebral vascular disease and in control subjects. Thromb Diath Haemorrh 1970; 23: 159-169
• 29 Couch JR, Hassanein RS. Platelet aggregation, stroke, and transient ischemic attack in middle-aged and elderly patients. Neurology 1976; 26: 888-895
• 30 Iwamoto T, Kubo H, Takasaki M. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger’s disease. Stroke 1995; 26: 52-56
• 31 Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75: 128-138
• 32 Rinder HM, Snyder EL, Bonan JL, Napychank PA, Malkus H, Smith BR. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and p-thromboglobulin release. Transfusion 1993; 33: 25-29
• 33 Larsen E, Celi A, Gilbert GE, Furie B, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM Protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989; 59: 305-312
• 34 Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu Y-M, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992; 359: 848-851
• 35 Garcia JH, Ho KL, Caccamo DV. Pathology of Stroke. In: Stroke: Pathophysiology, Diagnosis, and Management. Barnett HJ M, Mohr JP, Stein BM, Yatsu FM. eds New York, NY; Churchill Livingstone Inc.: 1992. pp 125-145
• 36 DeGraba TJ, Fisher M, Yatsu FM. Atherogenesis and Strokes. In: Stroke: Pathophysiology, Diagnosis, and Management. Barnett HJ M, Mohr JP, Stein BM, Yatsu FM. eds New York, NY; Churchill Livingstone Inc.: 1992. pp 29-48
• 37 Fisher CM. Capsular infarcts with underlying vascular lesions. Arch Neurol 1979; 36: 65-73
• 38 Futrell N, Millikan C. The fallacy of the lacune hypothesis. Stroke 1990; 21: 1251-1257